Author： Peter Johannsen
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.18, Iss.12, 2004-01, pp. : 757-768
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Is Long-Term Treatment of Alzheimer's Disease with Cholinesterase Inhibitor Therapy Justified?
By Seltzer Ben
Drugs & Aging, Vol. 24, Iss. 11, 2007-01 ,pp. :
Access to resources
Recommend
A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimers Disease
By Wilcock G.
Drugs & Aging, Vol. 20, Iss. 10, 2003-01 ,pp. :
Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimers Disease
By Jönsson L.
PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. :